Back to Journals » OncoTargets and Therapy » Volume 7

The potential clinical applications and prospects of microRNAs in lung cancer

Authors Gao Y, Gao F, Ma J, Sun W, Song L

Received 11 February 2014

Accepted for publication 6 April 2014

Published 4 June 2014 Volume 2014:7 Pages 901—906


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Ying Gao,1 Fei Gao,2,* Jin-lu Ma,1,* Wen-ze Sun,1 Li-ping Song1

1Department of Radiotherapy Oncology, First Affiliated Hospital of Medical College of Xi'an Jiaotong University, 2Department of Neurology, First Affiliated Hospital of Xi'an Medical University, Xi'an, People's Republic of China

*These authors contributed equally to this work

Abstract: Lung cancer is the major cause of cancer deaths worldwide due to its late diagnosis and poor outcome. Understanding genomic medicine may widen our vision into the oncogenesis of lung cancer and may open the door to improvements in the clinical management of lung cancer. It is well known that almost half of all genes are regulated by microRNAs (miRNAs). This review focuses on the role of miRNAs in lung cancer and also touches on the value of miRNA-based novel therapies for lung cancers.

Keywords: microRNA, lung cancer, biomarker, chemotherapy, radiotherapy

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]